February 2026
The U.S. in vitro diagnostics market size is evaluated at USD 35.43 billion in 2025 and is predicted to surpass around USD 43.49 billion by 2035 with a CAGR of 2.07%.
June 2026
The global in vitro diagnostics (IVD) market size accounted for USD 104.01 billion in 2025 and is expected to reach USD 135.76 billion by 2035.
May 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17Â million in 2026, with a CAGR of 5.09%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
November 2025
The in-vitro diagnostics enzymes market size is evaluated at USD 2.49 billion in 2025 and is expected to attain around USD 4.58 billion by 2035 with a CAGR of 6.28%
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
July 2025
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,500 million by 2034 from USD 790 million in 2024 with a notable CAGR of 12.21%.
June 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 154.02 million in 2025, with a CAGR of 2.99%.
June 2026
The U.S. concierge medicine market size is valued at USD 6.55 billion in 2025 and is projected to be worth around USD 12.75 billion by 2035 with CAGR of 6.88%.
June 2026
The global veterinary diagnostics market size is estimated to hit around USD 30.47 billion by 2035 increasing from USD 11.83 billion in 2025, with a CAGR of 9.92%.
June 2026
The global point-of-care diagnostics market size is exhibited at USD 64.08 billion in 2025 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
June 2026
The global U.S. regenerative medicine market size was evaluated at USD 19.77 billion in 2025 and is predicted to hit around USD 102.23 billion by 2035, growing at a CAGR of 17.86%.
June 2026
The U.S. clinical trial supply and logistics market size was evaluated at USD 1.54 billion in 2025 and is predicted to hit around USD 3.13 billion by 2035, growing at a CAGR of 7.35%.
June 2026
The U.S. cell therapy manufacturing market size was evaluated at USD 1.71 billion in 2025 and is predicted to hit around USD 6.56 billion by 2035, growing at a CAGR of 14.39%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
June 2026
The U.S. blood pressure monitoring devices market size is projected to surpass around USD 1,476.66 million by 2035 from USD 721.30 million in 2025, with a notable CAGR of 7.43%.
June 2026
The U.S. brain computer interface market size is valued at USD 617.60 million in 2025 and is projected to hit around USD 3,057.40 million by 2035 with a CAGR of 17.34%.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
June 2026
The U.S. non-invasive aesthetic treatment market size is projected to hit around USD 16.43 billion by 2035, from USD 8.03 billion in 2025, with a notable CAGR of 7.42%.
June 2026
The U.S. insulin pump market size was evaluated at USD 2.29 billion in 2025 and is predicted to hit around USD 5.13 billion by 2035, growing at a CAGR of 8.40%.
June 2026
The U.S. retail clinics market size reached USD 4.18Â billion in 2025 and is projected to hit around USD 9.05 billion by 2035, growing at a notable CAGR of 8.03%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The artificial intelligence in diagnostics market size was calculated at USD 1.94 billion in 2025 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The U.S. compounding pharmacies market size is valued at USD 6.45 billion in 2025 and is expected to hit around USD 11.52 billion by 2035, growing at a CAGR of 5.97%.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
April 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 19.17%.
April 2026
The U.S. imaging services market size is expected to increase from USD 154.11 billion in 2025 and is projected to hit around USD 250.10 billion by 2035 with a CAGR of 4.96%.
March 2026
The U.S. medical affairs outsourcing market size was exhibited at USD 625.10 million in 2025 and is projected to touch USD 1,218.8 million by 2035, registering a CAGR of 6.91% from 2026 to 2035.
March 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 4.48 billion in 2025 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com